A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson’s disease

References

• Asselah T, Durantel D, Pasmant E, et al. COVID-19: discovery, diagnostics and drug development. J Hepatol. 2021;74(1):168–184. doi: 10.1016/j.jhep.2020.09.031
   PubMed Web of Science ®Google Scholar
• Johns Hopkins University and Medicine Coronavirus Resource Center. (accessed Aug 30, 2022). https://coronavirus.jhu.edu
   Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [published correction appears in nature. Nature. 2020;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021;23(1):14 [Published 2021 Jan 5]. doi: 10.1208/s12248-020-00532-2
   PubMed Web of Science ®Google Scholar
• Nardo AD, Schneeweiss-Gleixner M, Bakail M, et al. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41(1):20–32. doi: 10.1111/liv.14730
   PubMed Web of Science ®Google Scholar
• Abboud H, Abboud FZ, Kharbouch H, et al. COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the Nervous System. World Neurosurg. 2020;140:49–53. doi: 10.1016/j.wneu.2020.05.193
   PubMed Web of Science ®Google Scholar
• Fisicaro F, Di Napoli M, Liberto A, et al. Neurological sequelae in patients with COVID-19: a histopathological perspective. Int J Environ Res Public Health. 2021;18(4):1415. doi: 10.3390/ijerph18041415
   PubMed Web of Science ®Google Scholar
• Zubair AS, McAlpine LS, Gardin T, et al. Neuropathogenesis and neurologic manifestations of the Coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018–1027. doi: 10.1001/jamaneurol.2020.2065IF:29.0Q1
   PubMed Web of Science ®Google Scholar
• Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): what do we know till now? Arab J Gastroenterol. 2020;21(1):3–8. doi: 10.1016/j.ajg.2020.03.002
   PubMed Web of Science ®Google Scholar
• Leung M, Aronowitz PB, Medici V. The present and future challenges of Wilson’s disease diagnosis and treatment. Clin Liver Dis. 2021;17(4):267–270 [Published 2021 May 1]. doi: 10.1002/cld.1041
   Google Scholar
• Xie JJ, Wu ZY. Wilson's Disease in China. Neurosci Bull. 2017;33(3):323–370. doi: 10.1007/s12264-017-0107-4
   PubMed Web of Science ®Google Scholar
• Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103–113. doi: 10.1016/S1474-4422(14)70190-5
   PubMed Web of Science ®Google Scholar
• Wang T, Wu L, Chen Q, et al. Copper deposition in Wilson’s disease causes male fertility decline by impairing reproductive hormone release through inducing apoptosis and inhibiting ERK signal in hypothalamic-pituitary of mice. Front Endocrinol. 2022 [Published 2022 Aug 5];13:961748.
   PubMed Web of Science ®Google Scholar
• Huang Z, Xu S, Liu J, et al. Effectiveness of inactivated and Ad5-nCov COVID-19 vaccines against SARS-CoV-2 omicron BA. 2 variant infection, severe illness, and death. BMC Med. 2022;20(1):400 [Published 2022 Oct 20]. doi: 10.1186/s12916-022-02606-8
   PubMed Web of Science ®Google Scholar
• Fiolet T, Kherabi Y, MacDonald CJ, et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–221. doi: 10.1016/j.cmi.2021.10.005
   PubMed Web of Science ®Google Scholar
• Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 2021;375:e068665. Published 2021 Dec 16. doi: 10.1136/bmj-2021-068665.
   PubMedGoogle Scholar
• Marcucci R, Marietta M. Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Intern Emerg Med. 2021;16(5):1113–1119. doi: 10.1007/s11739-021-02793-x
   PubMed Web of Science ®Google Scholar
• Avci E, Abasiyanik F. Autoimmune hepatitis after SARS-CoV-2 vaccine: new-onset or flare-up? J Autoimmun. 2021;125:102745. doi: 10.1016/j.jaut.2021.102745
   PubMed Web of Science ®Google Scholar
• Cirillo N, Doan R. Bell’s palsy and SARS-CoV-2 vaccines-an unfolding story. Lancet Infect Dis. 2021;21(9):1210–1211. doi: 10.1016/S1473-3099(21)00273-5
   PubMed Web of Science ®Google Scholar
• Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022;145(1):5–9. doi: 10.1111/ane.13550
   PubMed Web of Science ®Google Scholar
• Alhumaid S, Al Mutair A, Rabaan AA, et al. New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review. BMC Gastroenterol. 2022;22(1):433 [Published 2022 Oct 13]. doi: 10.1186/s12876-022-02507-3
   PubMed Web of Science ®Google Scholar
• Rocco A, Sgamato C, Compare D, et al. Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality. J Hepatol. 2021;75(3):728–729. doi: 10.1016/j.jhep.2021.05.038
   PubMed Web of Science ®Google Scholar
• Izzedine H, Bonilla M, Jhaveri KD. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial? Nephrol Dial Transplant. 2021;36(9):1565–1569. doi: 10.1093/ndt/gfab215
   PubMed Web of Science ®Google Scholar
• Nagai K, Kageyama M, Iwase M, et al. A young adult with nephrotic syndrome following COVID-19 vaccination. CEN Case Rep. 2022;11(3):397–398. doi: 10.1007/s13730-021-00673-z
   PubMed Web of Science ®Google Scholar
• Hummel A, Oniszczuk J, Kervella D, et al. Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases. Clin Kidney J. 2022;15(8):1574–1582 [Published 2022 May 6]. doi: 10.1093/ckj/sfac134
   PubMed Web of Science ®Google Scholar
• Candelli M, Rossi E, Valletta F, et al. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Br J Haematol. 2021;194(3):547–549. doi: 10.1111/bjh.17508
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. (accessed Aug 30, 2022). http://www.nhc.gov.cn/
   Google Scholar
• Li LY, Zhu XQ, Tao WW, et al. Acute onset neurological symptoms in Wilson disease after traumatic, surgical or emotional events: a cross-sectional study. Medicine (Baltimore). 2019;98(26):e15917. doi: 10.1097/MD.0000000000015917
   PubMed Web of Science ®Google Scholar
• Lubnow M, Schmidt B, Fleck M, et al. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: balancing immunosuppression. Int J Infect Dis. 2021;103:624–627. doi: 10.1016/j.ijid.2020.12.047
   PubMed Web of Science ®Google Scholar
• Volpert HM, Pfeiffenberger J, Gröner JB, et al. Comparative assessment of clinical rating scales in Wilson’s disease. BMC neurol. 2017;17(1):140 [Published 2017 Jul 21]. doi: 10.1186/s12883-017-0921-3
   PubMedGoogle Scholar
• Vitiello A, Ferrara F, Troiano V, et al. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology. 2021;29(5):1357–1360. doi: 10.1007/s10787-021-00847-2
   PubMed Web of Science ®Google Scholar
• Du P, Li D, Wang A, et al. A systematic review and meta-analysis of risk factors associated with severity and death in COVID-19 patients. Can J Infect Dis Med Microbiol. 2021 [Published 2021 Apr 10];2021:6660930.
   PubMedGoogle Scholar
• Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers. 2018;4(1):21. doi: 10.1038/s41572-018-0018-3
   PubMedGoogle Scholar
• Zhuang YP, Zhong HJ. Impact of COVID-19 on the clinical status of patients with Wilson disease. World J Gastroenterol. 2021;27(26):4248–4251. doi: 10.3748/wjg.v27.i26.4248
   PubMed Web of Science ®Google Scholar
• WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization. https://covid19.who.int/
   Google Scholar
• Shroff H, Satapathy SK, Crawford JM, et al. Liver injury following SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022;76(1):211–214. doi: 10.1016/j.jhep.2021.07.024
   PubMed Web of Science ®Google Scholar
• Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 [Published 2021 Jul 9];70(27):977–982. doi: 10.15585/mmwr.mm7027e2
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia [published correction appears in. N Engl J Med.2021;384(23):2254–2256. doi: 10.1056/NEJMe2106315
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang W, Li X, et al. Clinical and genetic characterization of a large cohort of patients with Wilson’s disease in China. Transl Neurodegener. 2022 [Published 2022 Feb 28];11(1):13 . doi: 10.1186/s40035-022-00287-0
   PubMed Web of Science ®Google Scholar
• The epidemic distribution of COVID-19. (accessed Aug 30, 2022).https://2019ncov.chinacdc.cn/2019-nCoV/
   Google Scholar
• Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–251. doi: 10.1016/j.puhe.2021.02.025
   PubMed Web of Science ®Google Scholar
• Lu L, Xiong W, Mu J, et al. The potential neurological effect of the COVID-19 vaccines: a review. Acta Neurol Scand. 2021;144(1):3–12. doi: 10.1111/ane.13417
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. (accessed Aug 30, 2022). http://www.nhc.gov.cn
   Google Scholar
• Lanza G, Godani M, Ferri R, et al. Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease. World J Gastroenterol. 2021;27(39):6733–6736. doi: 10.3748/wjg.v27.i39.6733
   PubMed Web of Science ®Google Scholar
• Chen M, Yuan Y, Zhou Y, et al. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials. Infect Dis Poverty. 2021;10(1):94 [Published 2021 Jul 5]. doi: 10.1186/s40249-021-00878-5
   PubMed Web of Science ®Google Scholar
• García-Grimshaw M, Ceballos-Liceaga SE, Hernández-Vanegas LE, et al. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin Immunol. 2021;229:108786. doi: 10.1016/j.clim.2021.108786
   PubMed Web of Science ®Google Scholar
• Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021;21(1):39–51. doi: 10.1016/S1473-3099(20)30831-8
   PubMed Web of Science ®Google Scholar
• Klein SL, Jedlicka A, Pekosz A. The xs and Y of immune responses to viral vaccines [published correction appears in Lancet Infect Dis. Lancet Infect Dis. 2010 Nov;10(5):338–349. doi: 10.1016/S1473-3099(10)70049-9
   PubMed Web of Science ®Google Scholar
• Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9–15. doi: 10.1093/trstmh/tru167
   PubMed Web of Science ®Google Scholar
• Zhu JS, Zhang MX, Chien CW, et al. Sex differences in adverse reactions to an inactivated SARS-CoV-2 vaccine among medical staff in China. Front Med. 2021 [Published 2021 Sep 8];8:731593.
   PubMed Web of Science ®Google Scholar
• Xiong X, Yuan J, Li M, et al. Age and gender disparities in adverse events following COVID-19 vaccination: Real-World evidence based on big data for risk management. Front Med. 2021 [Published 2021 Jul 19];8:700014.
   Web of Science ®Google Scholar